BioSpace News Archive

Continuous research on human body structure has paved way for technological advancements and innovation of fitness equipment, thus escalating the development of the global physical fitness equipment market.

PureTech Health plc is pleased to note that its Founded Entity, Akili Interactive announced collaborations with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19.

EXACT THERAPEUTICS AS, a clinical stage precision medicine company utilizing Acoustic Cluster Therapy across multiple therapeutic areas, announced the appointment of Dominic Moreland as Chief Financial Officer who will be based at the London office of EXACT-Tx in White City.

RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM in advanced clinical development to treat COVID-19 induced respiratory disorders, announced the appointment of J.J. Scherpbier of Sonsbeek Pharma Consultancy B.V. as Manufacturing and Supply Chain Consultant effective April 01, 2021.

Rapid adoption of advanced technology and increasing research & development activities are spurring sales

The healthcare regulatory affairs outsourcing market is experiencing significant growth owing to services to Clinical Research Organizations.

Pat Levitt, PhD, Children’s Hospital Los Angeles’ Chief Scientific Officer and Director of The Saban Research Institute, has been appointed to the board that oversees the California Institute for Regenerative Medicine.

G1 Therapeutics, Inc., a commercial-stage oncology company, announced that G1’s Chief Executive Officer Jack Bailey will participate in the 20th Annual Needham Virtual Healthcare Conference.

Pfizer Inc. announced that the U.S. Food and Drug Administration has extended the priority review period for the New Drug Application for abrocitinib for the treatment of adults and adolescents with moderate to severe atopic dermatitis.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced a poster presentation at the upcoming 2021 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics taking place April 13-16, 2021.